Most Popular
1. It’s a New Macro, the Gold Market Knows It, But Dead Men Walking Do Not (yet)- Gary_Tanashian
2.Stock Market Presidential Election Cycle Seasonal Trend Analysis - Nadeem_Walayat
3. Bitcoin S&P Pattern - Nadeem_Walayat
4.Nvidia Blow Off Top - Flying High like the Phoenix too Close to the Sun - Nadeem_Walayat
4.U.S. financial market’s “Weimar phase” impact to your fiat and digital assets - Raymond_Matison
5. How to Profit from the Global Warming ClImate Change Mega Death Trend - Part1 - Nadeem_Walayat
7.Bitcoin Gravy Train Trend Forecast 2024 - - Nadeem_Walayat
8.The Bond Trade and Interest Rates - Nadeem_Walayat
9.It’s Easy to Scream Stocks Bubble! - Stephen_McBride
10.Fed’s Next Intertest Rate Move might not align with popular consensus - Richard_Mills
Last 7 days
US Presidential Election Year Stock Market Seasonal Trend - 29th Nov 24
Who controls the past controls the future: who controls the present controls the past - 29th Nov 24
Gold After Trump Wins - 29th Nov 24
The AI Stocks, Housing, Inflation and Bitcoin Crypto Mega-trends - 27th Nov 24
Gold Price Ahead of the Thanksgiving Weekend - 27th Nov 24
Bitcoin Gravy Train Trend Forecast to June 2025 - 24th Nov 24
Stocks, Bitcoin and Crypto Markets Breaking Bad on Donald Trump Pump - 21st Nov 24
Gold Price To Re-Test $2,700 - 21st Nov 24
Stock Market Sentiment Speaks: This Is My Strong Warning To You - 21st Nov 24
Financial Crisis 2025 - This is Going to Shock People! - 21st Nov 24
Dubai Deluge - AI Tech Stocks Earnings Correction Opportunities - 18th Nov 24
Why President Trump Has NO Real Power - Deep State Military Industrial Complex - 8th Nov 24
Social Grant Increases and Serge Belamant Amid South Africa's New Political Landscape - 8th Nov 24
Is Forex Worth It? - 8th Nov 24
Nvidia Numero Uno in Count Down to President Donald Pump Election Victory - 5th Nov 24
Trump or Harris - Who Wins US Presidential Election 2024 Forecast Prediction - 5th Nov 24
Stock Market Brief in Count Down to US Election Result 2024 - 3rd Nov 24
Gold Stocks’ Winter Rally 2024 - 3rd Nov 24
Why Countdown to U.S. Recession is Underway - 3rd Nov 24
Stock Market Trend Forecast to Jan 2025 - 2nd Nov 24
President Donald PUMP Forecast to Win US Presidential Election 2024 - 1st Nov 24
At These Levels, Buying Silver Is Like Getting It At $5 In 2003 - 28th Oct 24
Nvidia Numero Uno Selling Shovels in the AI Gold Rush - 28th Oct 24
The Future of Online Casinos - 28th Oct 24
Panic in the Air As Stock Market Correction Delivers Deep Opps in AI Tech Stocks - 27th Oct 24
Stocks, Bitcoin, Crypto's Counting Down to President Donald Pump! - 27th Oct 24
UK Budget 2024 - What to do Before 30th Oct - Pensions and ISA's - 27th Oct 24
7 Days of Crypto Opportunities Starts NOW - 27th Oct 24
The Power Law in Venture Capital: How Visionary Investors Like Yuri Milner Have Shaped the Future - 27th Oct 24
This Points To Significantly Higher Silver Prices - 27th Oct 24

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

Pfizer shares plunge after new heart drug Torcetrapib fails clinical trials

Companies / Strategic News Dec 04, 2006 - 10:45 PM GMT

By: Phillipa_Green

Companies

Pfizer shares fell by nearly 12 per cent after the worlds largest drug manufacturer, announced it was halting trails of its heart medicine Torcetrapib , after it revealed deaths and cardiovascular problems among people taking the drug during the clinical trials. The stock was also downgraded by several market analysts on concern that Pfizer's revenue growth will now weaken.

Pfizer shares plunge after new heart drug Torcetrapib fails clinical trials


Pfizer had planned Torcetrapib to replace its existing cholesterol drug Lipitor, which accounts for a quarter of its $51 billion of annual revenue and almost half of Pfizers net income, for when the drugs patent expires in some four years. Lipitor is the world's biggest selling drug and it and another 5 drugs also to have their patents expire in the coming years, account for half of the company's revenues.

The trials resulted in 82 patients died in an trial of 15,000, which was 60% higher than those taking Lipitor. Drugs such as Lipitor, called statins, lower the bad cholesterol (LDL) and cut risks of heart related deaths by about one third. Scientists had hoped that new medicines that raise the good cholesterol (HDL) levels, such as Torcetrapib, would result in lower risks.

Pfizers main competitors immediately rose on the news sending AstraZeneca, Merc and Roche soaring as they are developing rival good cholesterol products.


© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Comments

TessrTorn
15 Jul 08, 07:43
Apple Web service falters on eve of iPhone launch

Apple Inc.'s new data synching service got off to a rocky start Thursday, as some users were denied access to their accounts just hours before the next-generation iPhone is slated to go on sale.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in